| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Lars Klareskog | Q5912759 |
| Lars Alfredsson | Q30349390 | ||
| Leendert A Trouw | Q40406948 | ||
| Rene E Toes | Q42494390 | ||
| Diane van der Woude | Q55314080 | ||
| Tom Huizinga | Q77086497 | ||
| Karin Lundberg | Q97546576 | ||
| Willem Verduijn | Q114402417 | ||
| Tineke J van Wesemael | Q114563679 | ||
| P2093 | author name string | Xia Jiang | |
| Jing Shi | |||
| Camilla Bengtsson | |||
| Henrik Källberg | |||
| Lena Israelsson | |||
| Hulda Hreggvidsdottir | |||
| Vivi Malmström | |||
| P2860 | cites work | Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 |
| Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis | Q24812184 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases | Q35201241 | ||
| Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. | Q35408694 | ||
| Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis | Q35638299 | ||
| Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis | Q35752661 | ||
| Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis | Q38016067 | ||
| Autoimmunity in rheumatoid arthritis: different antigens--common principles | Q38068700 | ||
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
| The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens | Q42598147 | ||
| Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile | Q42651662 | ||
| A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination | Q42676934 | ||
| Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis | Q44616885 | ||
| Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins | Q44687984 | ||
| Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method | Q46737305 | ||
| Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis | Q46875208 | ||
| Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients | Q47965354 | ||
| Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis. | Q53067796 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients | Q58234939 | ||
| An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility | Q58234969 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| autoantibody | Q785022 | ||
| rheumatoid arthritis | Q187255 | ||
| cigarette smoking | Q67433631 | ||
| P304 | page(s) | 1761-1768 | |
| P577 | publication date | 2014-05-08 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies | |
| P478 | volume | 73 |
| Q89882317 | A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis |
| Q53393095 | Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. |
| Q36107157 | Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies |
| Q36535109 | Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis |
| Q35251912 | Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. |
| Q42643869 | Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor |
| Q58234714 | Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent: Fig. 1 |
| Q35149378 | Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage |
| Q38602504 | Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort |
| Q33865776 | Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients |
| Q37470470 | Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts. |
| Q36619299 | Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology. |
| Q39794799 | Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies |
| Q64122268 | Antibody-dependent and -independent mechanisms of inflammatory arthritis |
| Q92034749 | Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology |
| Q39169435 | Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. |
| Q51063652 | Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. |
| Q47884810 | Editorial: Anti-Citrullinated Protein Antibody, Anti-Carbamylated Protein Antibody, and Rheumatoid Arthritis: Azurophilic Granules Sing the Blues. |
| Q38813384 | Family history of rheumatoid arthritis: an old concept with new developments |
| Q92052787 | HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications |
| Q36968767 | Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis |
| Q90733183 | Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts |
| Q50321197 | Impact of fibrinogen carbamylation on fibrin clot formation and stability |
| Q48010750 | Mechanisms and consequences of carbamoylation |
| Q36082681 | Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis |
| Q23917420 | Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers |
| Q37442781 | Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases |
| Q39741892 | Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis. |
| Q41516833 | Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue |
| Q35834431 | Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study. |
| Q46640361 | Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. |
| Q21146625 | Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides |
| Q38851071 | Smoking and obesity in systemic lupus erythematosus: a cross-sectional study |
| Q39139958 | Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study. |
| Q58234648 | The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor |
| Q39029106 | The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting |
| Q37351609 | The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. |
| Q38815526 | The role of autoantibodies in the pathophysiology of rheumatoid arthritis |
| Q26999006 | The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis |
| Q61452098 | The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis |
| Q43158822 | The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis. |
| Q26744033 | Therapeutic implications of autoantibodies in rheumatoid arthritis |
| Q41697121 | Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients. |
Search more.